These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38082255)

  • 21. Measuring freezing of gait during daily-life: an open-source, wearable sensors approach.
    Mancini M; Shah VV; Stuart S; Curtze C; Horak FB; Safarpour D; Nutt JG
    J Neuroeng Rehabil; 2021 Jan; 18(1):1. PubMed ID: 33397401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy.
    Ghourchian S; Mousavi A; Zamani B; Shahidi G; Rohani M
    Clin Neurol Neurosurg; 2019 Aug; 183():105383. PubMed ID: 31181432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Gait Analysis in Progressive Supranuclear Palsy and Parkinson's Disease.
    Hatanaka N; Sato K; Hishikawa N; Takemoto M; Ohta Y; Yamashita T; Abe K
    Eur Neurol; 2016; 75(5-6):282-9. PubMed ID: 27288001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease.
    Price S; Paviour D; Scahill R; Stevens J; Rossor M; Lees A; Fox N
    Neuroimage; 2004 Oct; 23(2):663-9. PubMed ID: 15488416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson's disease (PD).
    Swallow DMA; Counsell CE
    J Neurol; 2023 Jul; 270(7):3464-3474. PubMed ID: 36971841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
    Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.
    Di Lazzaro G; Ricci M; Al-Wardat M; Schirinzi T; Scalise S; Giannini F; Mercuri NB; Saggio G; Pisani A
    J Parkinsons Dis; 2020; 10(1):113-122. PubMed ID: 31594252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor Performance Assessment in Parkinson's Disease: Association between Objective In-Clinic, Objective In-Home, and Subjective/Semi-Objective Measures.
    Toosizadeh N; Mohler J; Lei H; Parvaneh S; Sherman S; Najafi B
    PLoS One; 2015; 10(4):e0124763. PubMed ID: 25909898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative clinical assessment of motor function during and following LSVT-BIG® therapy.
    Flood MW; O'Callaghan BPF; Diamond P; Liegey J; Hughes G; Lowery MM
    J Neuroeng Rehabil; 2020 Jul; 17(1):92. PubMed ID: 32660495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy.
    Quattrone A; Crasà M; Morelli M; Vescio B; Augimeri A; Gramigna V; Quattrone A
    Parkinsonism Relat Disord; 2022 Jun; 99():84-90. PubMed ID: 35642995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions.
    Dale ML; Silva-Batista C; de Almeida FO; Horak FB
    Front Neurol; 2023; 14():1212185. PubMed ID: 37426438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of Parkinson's disease and essential tremor based on balance and gait characteristics from wearable motion sensors via machine learning techniques: a data-driven approach.
    Moon S; Song HJ; Sharma VD; Lyons KE; Pahwa R; Akinwuntan AE; Devos H
    J Neuroeng Rehabil; 2020 Sep; 17(1):125. PubMed ID: 32917244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Fall Counts Using Wearable Sensors: A Novel Digital Biomarker for Parkinson's Disease.
    Greene BR; Premoli I; McManus K; McGrath D; Caulfield B
    Sensors (Basel); 2021 Dec; 22(1):. PubMed ID: 35009599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
    Neely KA; Planetta PJ; Prodoehl J; Corcos DM; Comella CL; Goetz CG; Shannon KL; Vaillancourt DE
    PLoS One; 2013; 8(3):e58403. PubMed ID: 23505500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.